In a study of more than 600,000 pediatric patients, researchers found a higher risk of type 2 diabetes within 6 months of a COVID-19 diagnosis compared with other respiratory infections, especially among...
A recent retrospective cohort study suggests a potential long-term link between COVID-19 and increased risk for autoimmune conditions, underscoring the importance of follow-up care for those previously...
A specialized inpatient sickle cell disease (SCD) consult service led to improved pain management, shorter hospital stays and expanded use of individualized pain plans for patients with SCD.
In a phase 3 trial, inebilizumab, a monoclonal antibody targeting CD19+ B cells, reduced flare rates and improved treatment-free and glucocorticoid-free remission in patients with immunoglobulin G4-related...
Environmental detection of SARS-CoV-2 in hospital staff areas may offer early insights into impending COVID-19 outbreaks, according to recent research out of Canada.
A phase 3 trial shows that adding voclosporin to mycophenolate mofetil and low-dose glucocorticoids leads to higher rates of complete renal response and faster reduction in proteinuria for patients with...
A recent study found that single-dose intraoperative methadone reduced opioid consumption in children undergoing tonsillectomy compared with fentanyl, with no impact on postoperative pain scores or serious...
A clinical trial suggests semaglutide significantly reduces abdominal fat in HIV-associated lipohypertrophy, but the potential for adverse events warrant further investigation.
Researchers report on the first safety and efficacy of mosunetuzumab, a CD20xCD3 T-cell engaging bispecific antibody, for patients with relapsed/refractory Mantle cell lymphoma. This study was presented at...
